Verition Fund Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Sell |
|
|||||
|
2025
Q1 | $2.91M | Buy |
|
|||||
|
2024
Q4 | $683K | Sell |
|
|||||
|
2024
Q3 | $4.8M | Buy |
|
|||||
|
2024
Q2 | $1.8M | Buy |
|
|||||
|
2024
Q1 | $657K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $246K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $966K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $393K | Sell |
|
|||||
|
2021
Q4 | $1.25M | Buy |
|
|||||
|
2021
Q3 | $202K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $258K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $611K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $887K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $437K | Sell |
|
|||||
|
2018
Q1 | $649K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $1.06M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $574K | Buy |
|
|||||
|
2014
Q4 | $272K | Sell |
|
|||||
|
2014
Q3 | $291K | Buy |
|